Athanasios Polychronis

Postoperative dose-dense sequential chemotherapy with epirubicin, followed by CMF with or without paclitaxel, in patients with high-risk operable breast cancer: a randomized phase III study conducted by the Hellenic Cooperative Oncology Group

George Fountzilas, Dimosthenis Skarlos, Urania Dafni et al. · Annals of Oncology · 2005 · 99 citations · Full text

Surgical Oncology, Breast Oncology, Medicine +5

The role of Ki-67 in the proliferation and prognosis of breast cancer molecular classification subtypes

George P. Stathopoulos, Nikolaos Malamos, Christos Markopoulos et al. · Anti-Cancer Drugs · 2014 · 44 citations · Full text

Breast Oncology, Oncology, Ki-67 Biomarkers +13

Pre- and postoperative chemoendocrine treatment with or without postoperative radiotherapy for localy advanced breast cancer

Anaxagoras N. Papaioannou, B Lissaios, S Vasilaros et al. · Cancer · 1983 · 35 citations

Down-regulation of kallikrein-related peptidase 5 (KLK5) expression in breast cancer patients: a biomarker for the differential diagnosis of breast lesions

Margaritis Avgeris, Georgia Papachristopoulou, Athanasios Polychronis et al. · Clinical Proteomics · 2011 · 25 citations · Full text